Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nitric Oxide, LPS and the Pathogenesis of Asthma - Phase II

NCT00643058 is registered in ClinicalTrials.gov with John Sundy as lead sponsor.

NCT NCT00643058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00643058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nitric Oxide, LPS and the Pathogenesis of Asthma - Phase II
Lead sponsor
John Sundy
Phase
Phase 1
Overall status
Terminated
Start date
April 30, 2003
Completion date
December 31, 2009
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy